---
title: "CICC Sticks to Their Buy Rating for Laekna, Inc. (2105)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283298518.md"
description: "In a report released yesterday, from CICC maintained a Buy rating on Laekna, Inc., with a price target of HK$27.02.Claim 30% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Laekna, Inc. is a Strong Buy with an average price target of HK$29.91."
datetime: "2026-04-20T05:35:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283298518.md)
  - [en](https://longbridge.com/en/news/283298518.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283298518.md)
---

# CICC Sticks to Their Buy Rating for Laekna, Inc. (2105)

In a report released yesterday, from CICC maintained a Buy rating on Laekna, Inc., with a price target of HK$27.02.

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on Laekna, Inc. is a Strong Buy with an average price target of HK$29.91.

### Related Stocks

- [02105.HK](https://longbridge.com/en/quote/02105.HK.md)
- [03908.HK](https://longbridge.com/en/quote/03908.HK.md)
- [601995.CN](https://longbridge.com/en/quote/601995.CN.md)

## Related News & Research

- [Bank of America Securities Reaffirms Their Buy Rating on Laekna, Inc. (2105)](https://longbridge.com/en/news/285640720.md)
- [Laekna’s Breast Cancer Drug LAE002 Hits Phase III PFS Goal, NDA in China Planned](https://longbridge.com/en/news/282760815.md)
- [Goldman Sachs Reaffirms Their Buy Rating on Prudential (PRU)](https://longbridge.com/en/news/286866728.md)
- [Maxim Group Sticks to Its Buy Rating for Newsmax Inc. Class B (NMAX)](https://longbridge.com/en/news/286573867.md)
- [Delhivery Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions](https://longbridge.com/en/news/286841705.md)